Managing Editor, Europe
Latest From Tom Gallen
People On The Move: Appointments At Orkla, PAGB, Afepadi
A round-up of the latest appointments in Europe's consumer health industry: Orkla Health names BioGaia's Ducellier as its CEO; PAGB makes changes to its board; and Afepadi names Uriach's Gispert as its president.
Germany's Dermapharm Looks To Future With Arkopharma As 2022 Sales Rise
Dermapharm has high hopes for 2023 as its acquisition of Arkopharma means the firm is now the number-one and number-three player respectively in the French and Spanish supplements markets.
Germany's Schwabe Sets Up JV In Brazil With Local Player Herbarium
Schwabe is looking to take a slice of Brazil's growing herbal medicines market by teaming up with local player Herbarium to launch a new joint venture in 2024.
People On The Move: Appointments At GSCF, Bayer, Shop Apotheke
A round-up of the latest appointments in the consumer health industry: the Global Self-Care Federation elects J&J's Raghunandanan as its chair; Bayer Consumer Health makes changes to its medical leadership; and Shop Apotheke hires ex-DocMorris CEO to lead company.
Firm Touting ACV As Cure-All Says It Can’t Afford Trials To Back Up Claims
When investigated for promoting apple cider vinegar as a treatment for a myriad of ailments, from lowering cholesterol to preventing colds and flu, UK-based Willy's told the country's advertising regulator that trials to substantiate these claims were "prohibitively expensive."
EU Authorizes Cholesterol Lowering Health Claim For Supplement After 10 Year Wait
France's Laboratoire Lescuyer can now claim its Limicol botanical extract supplement "reduces blood LDL-cholesterol concentrations" after waiting more than 10 years for approval by the European Commission.